Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 26% ± 7% | |
| astrocyte | 5 studies | 29% ± 9% | |
| oligodendrocyte precursor cell | 4 studies | 17% ± 1% | |
| glutamatergic neuron | 4 studies | 47% ± 25% | |
| interneuron | 3 studies | 29% ± 15% | |
| neuron | 3 studies | 25% ± 7% | |
| GABAergic neuron | 3 studies | 47% ± 18% | |
| ependymal cell | 3 studies | 34% ± 13% | |
| oligodendrocyte | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 34% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 2279.27 | 2627 / 2642 | 99% | 24.10 | 699 / 705 |
| thymus | 100% | 1903.80 | 652 / 653 | 97% | 11.25 | 585 / 605 |
| prostate | 99% | 1024.95 | 243 / 245 | 96% | 11.66 | 484 / 502 |
| intestine | 97% | 901.63 | 939 / 966 | 95% | 16.34 | 501 / 527 |
| skin | 89% | 899.77 | 1619 / 1809 | 97% | 23.07 | 457 / 472 |
| pancreas | 98% | 660.13 | 321 / 328 | 88% | 8.88 | 156 / 178 |
| ovary | 84% | 570.18 | 152 / 180 | 100% | 36.77 | 429 / 430 |
| esophagus | 86% | 666.84 | 1241 / 1445 | 97% | 16.72 | 178 / 183 |
| adrenal gland | 100% | 843.86 | 258 / 258 | 81% | 6.71 | 186 / 230 |
| breast | 81% | 860.04 | 372 / 459 | 98% | 20.83 | 1096 / 1118 |
| uterus | 81% | 657.78 | 137 / 170 | 93% | 13.59 | 427 / 459 |
| bladder | 76% | 388.38 | 16 / 21 | 95% | 12.48 | 479 / 504 |
| lung | 71% | 598.69 | 408 / 578 | 90% | 11.81 | 1041 / 1155 |
| stomach | 60% | 299.27 | 215 / 359 | 96% | 17.27 | 274 / 286 |
| kidney | 99% | 950.15 | 88 / 89 | 44% | 3.57 | 400 / 901 |
| ureter | 0% | 0 | 0 / 0 | 100% | 23.08 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 18.68 | 79 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 87% | 8.89 | 39 / 45 |
| adipose | 61% | 295.72 | 731 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 44% | 176.96 | 106 / 241 | 0% | 0 | 0 / 0 |
| liver | 15% | 61.82 | 33 / 226 | 24% | 1.98 | 96 / 406 |
| heart | 35% | 149.83 | 300 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 22% | 122.76 | 289 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.80 | 4 / 29 |
| muscle | 2% | 8.13 | 16 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.66 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
| GO_0099173 | Biological process | postsynapse organization |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | ARHGAP39 |
| Protein name | ARHGAP39 Rho GTPase-activating protein 39 |
| Synonyms | KIAA1688 |
| Description | |
| Accessions | Q9C0H5 A0A2X0SSG1 ENST00000276826.5 [Q9C0H5-1] ENST00000377307.7 [Q9C0H5-2] |